Wall Street Zen cut shares of Cybin (NASDAQ:HELP – Free Report) from a sell rating to a strong sell rating in a research report report published on Saturday morning,Wall Street Zen reports. Other equities research analysts have also issued reports about the company. Wells Fargo & Company assumed coverage on Cybin in a research report […]

Wall Street Zen lowered shares of Greenlight Capital Re (NASDAQ:GLRE – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning,Wall Street Zen reports. Separately, Weiss Ratings lowered shares of Greenlight Capital Re from a “buy (b)” rating to a “hold (c+)” rating in a research […]

Wall Street Zen cut shares of REalloys (NASDAQ:ALOY – Free Report) from a hold rating to a sell rating in a research note released on Saturday,Wall Street Zen reports. A number of other equities research analysts also recently commented on ALOY. Weiss Ratings reiterated a “sell (d-)” rating on shares of REalloys in a report […]

Wall Street Zen lowered shares of Spyglass Pharma (NASDAQ:SGP – Free Report) from a hold rating to a sell rating in a report published on Saturday morning,Wall Street Zen reports. SGP has been the subject of a number of other research reports. Weiss Ratings cut shares of Spyglass Pharma from a “sell (e+)” rating to […]

Wall Street Zen cut shares of FTC Solar (NASDAQ:FTCI – Free Report) from a sell rating to a strong sell rating in a report published on Saturday,Wall Street Zen reports. Other equities research analysts have also recently issued research reports about the company. Roth Capital set a $7.00 price target on FTC Solar and gave […]

Wall Street Zen cut shares of NextNav (NASDAQ:NN – Free Report) from a hold rating to a sell rating in a research report report published on Sunday,Wall Street Zen reports. NN has been the subject of a number of other research reports. Oppenheimer boosted their target price on NextNav from $25.00 to $50.00 and gave […]

Wall Street Zen lowered shares of AgomAb Therapeutics (NASDAQ:AGMB – Free Report) from a hold rating to a sell rating in a research note published on Sunday,Wall Street Zen reports. A number of other research firms have also recently commented on AGMB. Piper Sandler began coverage on AgomAb Therapeutics in a research report on Tuesday, […]

Wall Street Zen cut shares of Gevo (NASDAQ:GEVO – Free Report) from a sell rating to a strong sell rating in a research note released on Saturday,Wall Street Zen reports. A number of other research analysts have also weighed in on the stock. Weiss Ratings lowered shares of Gevo from a “sell (d-)” rating to […]

Wall Street Zen downgraded shares of Tvardi Therapeutics (NASDAQ:TVRD – Free Report) from a sell rating to a strong sell rating in a report published on Saturday,Wall Street Zen reports. A number of other analysts have also recently weighed in on TVRD. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tvardi Therapeutics in […]

Wall Street Zen cut shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) from a hold rating to a sell rating in a report released on Saturday morning,Wall Street Zen reports. Other research analysts have also issued research reports about the stock. Royal Bank Of Canada raised their price objective on shares of Edgewise Therapeutics from […]

Wall Street Zen cut shares of Genelux (NASDAQ:GNLX – Free Report) from a sell rating to a strong sell rating in a research note released on Saturday morning,Wall Street Zen reports. Other equities research analysts also recently issued research reports about the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Genelux in […]

Wall Street Zen lowered shares of Cal-Maine Foods (NASDAQ:CALM – Free Report) from a sell rating to a strong sell rating in a research note published on Saturday morning,Wall Street Zen reports. Other equities research analysts have also issued research reports about the company. Benchmark lowered Cal-Maine Foods from a “strong-buy” rating to a “hold” […]

Wall Street Zen cut shares of Sensei Biotherapeutics (NASDAQ:FTH – Free Report) from a hold rating to a sell rating in a report released on Saturday,Wall Street Zen reports. Several other analysts have also recently issued reports on FTH. Oppenheimer initiated coverage on Sensei Biotherapeutics in a report on Tuesday, July 28th. They issued an […]

Wall Street Zen downgraded shares of Richmond Mutual Bancorporation (NASDAQ:RMBI – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning,Wall Street Zen reports. Separately, Weiss Ratings raised Richmond Mutual Bancorporation from a “buy (b+)” rating to a “buy (a-)” rating in a report on Thursday, […]

Wall Street Zen lowered shares of Deep Fission (NASDAQ:FISN – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday morning,Wall Street Zen reports. A number of other research analysts have also weighed in on FISN. UBS Group set a $18.00 price target on shares of […]

Wall Street Zen cut shares of Gossamer Bio (NASDAQ:GOSS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Sunday morning,Wall Street Zen reports. GOSS has been the subject of a number of other reports. Leerink Partners upgraded Gossamer Bio from a “market perform” rating to […]